Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23567202)

1.

Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine.

Ren Q, Zhang JC, Fujita Y, Ma M, Wu J, Hashimoto K.

Pharmacol Biochem Behav. 2013 May;106:124-7. doi: 10.1016/j.pbb.2013.03.016. Epub 2013 Apr 6.

PMID:
23567202
2.

7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.

Ren Q, Zhang JC, Ma M, Fujita Y, Wu J, Hashimoto K.

Psychopharmacology (Berl). 2014 Jan;231(1):159-66. doi: 10.1007/s00213-013-3221-7. Epub 2013 Aug 10.

PMID:
23934209
3.

7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.

Tsai T, Klausmeyer A, Conrad R, Gottschling C, Leo M, Faissner A, Wiese S.

Mol Cell Neurosci. 2013 Sep;56:18-28. doi: 10.1016/j.mcn.2013.02.007. Epub 2013 Mar 14.

PMID:
23500004
4.

Modulatory effects of the novel TrkB receptor agonist 7,8-dihydroxyflavone on synaptic transmission and intrinsic neuronal excitability in mouse visual cortex in vitro.

Marongiu D, Imbrosci B, Mittmann T.

Eur J Pharmacol. 2013 Jun 5;709(1-3):64-71. doi: 10.1016/j.ejphar.2013.03.044. Epub 2013 Apr 6.

PMID:
23567067
5.

Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia.

Yang YJ, Li YK, Wang W, Wan JG, Yu B, Wang MZ, Hu B.

Pharmacol Biochem Behav. 2014 Jul;122:30-6. doi: 10.1016/j.pbb.2014.03.013. Epub 2014 Mar 21.

PMID:
24662915
6.

Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging.

Zeng Y, Liu Y, Wu M, Liu J, Hu Q.

J Alzheimers Dis. 2012;31(4):765-78. doi: 10.3233/JAD-2012-120886.

PMID:
22710915
7.

Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.

Andero R, Heldt SA, Ye K, Liu X, Armario A, Ressler KJ.

Am J Psychiatry. 2011 Feb;168(2):163-72. doi: 10.1176/appi.ajp.2010.10030326. Epub 2010 Dec 1.

8.

The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission.

Mantilla CB, Ermilov LG.

Muscle Nerve. 2012 Feb;45(2):274-6. doi: 10.1002/mus.22295.

9.

Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.

Jiang M, Peng Q, Liu X, Jin J, Hou Z, Zhang J, Mori S, Ross CA, Ye K, Duan W.

Hum Mol Genet. 2013 Jun 15;22(12):2462-70. doi: 10.1093/hmg/ddt098. Epub 2013 Feb 27.

10.

Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics.

Apawu AK, Maina FK, Taylor JR, Mathews TA.

ACS Chem Neurosci. 2013 May 15;4(5):895-904. doi: 10.1021/cn4000742. Epub 2013 May 8.

11.

O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity.

Liu X, Qi Q, Xiao G, Li J, Luo HR, Ye K.

Pharmacology. 2013;91(3-4):185-200. doi: 10.1159/000346920. Epub 2013 Feb 21.

PMID:
23445871
12.

Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor.

Liu X, Obianyo O, Chan CB, Huang J, Xue S, Yang JJ, Zeng F, Goodman M, Ye K.

J Biol Chem. 2014 Oct 3;289(40):27571-84. doi: 10.1074/jbc.M114.562561. Epub 2014 Aug 20.

PMID:
25143381
13.

The Small-Molecule TrkB Agonist 7, 8-Dihydroxyflavone Decreases Hippocampal Newborn Neuron Death After Traumatic Brain Injury.

Chen L, Gao X, Zhao S, Hu W, Chen J.

J Neuropathol Exp Neurol. 2015 Jun;74(6):557-67. doi: 10.1097/NEN.0000000000000199.

PMID:
25933388
14.

A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.

Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2687-92. doi: 10.1073/pnas.0913572107. Epub 2010 Jan 25.

15.

Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.

Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, Li SX, Shirayama Y, Hashimoto K.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu077. doi: 10.1093/ijnp/pyu077.

PMID:
25628381
16.

Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice.

Mizoguchi H, Yamada K.

Curr Neuropharmacol. 2011 Mar;9(1):109-12. doi: 10.2174/157015911795016976.

17.

Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling.

Wu CH, Hung TH, Chen CC, Ke CH, Lee CY, Wang PY, Chen SF.

PLoS One. 2014 Nov 21;9(11):e113397. doi: 10.1371/journal.pone.0113397. eCollection 2014.

18.

Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.

Chen H, Wu J, Zhang J, Fujita Y, Ishima T, Iyo M, Hashimoto K.

Psychopharmacology (Berl). 2012 Jul;222(1):37-45. doi: 10.1007/s00213-011-2619-3. Epub 2011 Dec 27.

PMID:
22200890
19.

Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.

Ago Y, Nakamura S, Uda M, Kajii Y, Abe M, Baba A, Matsuda T.

Neuropharmacology. 2006 Sep;51(4):914-22. Epub 2006 Jul 24.

PMID:
16863654
20.

TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender- dependent neuroprotection in mice after perinatal hypoxia and ischemia.

Uluc K, Kendigelen P, Fidan E, Zhang L, Chanana V, Kintner D, Akture E, Song C, Ye K, Sun D, Ferrazzano P, Cengiz P.

CNS Neurol Disord Drug Targets. 2013 May 1;12(3):360-70.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk